Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Horst

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
The American Journal of Gastroenterology|January 9, 2023
A Practical Guide to Use of RisankizumabSara Horst
Digestive Diseases and Sciences|August 13, 2014
Patient-reported outcomes in Crohn's disease: does race matter?Sara Horst
Digestive Diseases and Sciences|June 28, 2021
Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?Sara Horst
Gastroenterology Clinics of North America|August 12, 2014
The use of biologic agents in pregnancy and breastfeedingSara Horst, Sunanda Kane
Alimentary Pharmacology & Therapeutics|October 11, 2022
Editorial: maternal and paternal 5-aminosalicylic acid use-safe in conception and pregnancyAudrey Bennett, Sara Horst
Drug Design, Development and Therapy|February 7, 2023
Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn's Disease: Patient Selection and Reported OutcomesSara Horst, Raymond K Cross
The American Journal of Gastroenterology|February 20, 2026
Response to Lewis et alHasan Saleh, Sara Horst, Jami Kinnucan
Current Gastroenterology Reports|June 20, 2025
Applying Biomarkers in Treat-to-target Approach for IBDMegan Lutz, Sara Horst, Freddy Caldera
The American Journal of Gastroenterology|June 16, 2025
Dissatisfaction and Barriers in Electronic Health Record Use for Patients With Inflammatory Bowel Disease: A Nationwide Survey of Major IBD CentersHasan Saleh, Sara Horst, Jami Kinnucan
American Journal of Surgery|January 10, 2006
Abdominal positron-emission tomography lesions with increased standardized uptake values correlate with intraoperative findingsSara Horst, Ergun Kocak, Donn Young, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
The American Journal of Gastroenterology|January 9, 2023
A Practical Guide to Use of RisankizumabSara Horst
Digestive Diseases and Sciences|August 13, 2014
Patient-reported outcomes in Crohn's disease: does race matter?Sara Horst
Digestive Diseases and Sciences|June 28, 2021
Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?Sara Horst
Gastroenterology Clinics of North America|August 12, 2014
The use of biologic agents in pregnancy and breastfeedingSara Horst, Sunanda Kane
Alimentary Pharmacology & Therapeutics|October 11, 2022
Editorial: maternal and paternal 5-aminosalicylic acid use-safe in conception and pregnancyAudrey Bennett, Sara Horst
Drug Design, Development and Therapy|February 7, 2023
Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn's Disease: Patient Selection and Reported OutcomesSara Horst, Raymond K Cross
The American Journal of Gastroenterology|February 20, 2026
Response to Lewis et alHasan Saleh, Sara Horst, Jami Kinnucan
Current Gastroenterology Reports|June 20, 2025
Applying Biomarkers in Treat-to-target Approach for IBDMegan Lutz, Sara Horst, Freddy Caldera
The American Journal of Gastroenterology|June 16, 2025
Dissatisfaction and Barriers in Electronic Health Record Use for Patients With Inflammatory Bowel Disease: A Nationwide Survey of Major IBD CentersHasan Saleh, Sara Horst, Jami Kinnucan
American Journal of Surgery|January 10, 2006
Abdominal positron-emission tomography lesions with increased standardized uptake values correlate with intraoperative findingsSara Horst, Ergun Kocak, Donn Young, et al.
Pageof 5